| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |